JAN KEMNADE's research topics

JAN KEMNADE

Concepts (80)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with JAN KEMNADE's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JAN KEMNADE has written about over time.

Antigens, Neoplasm, 1 publications between 2012 and 2012, average publication date March 2012. CD40 Antigens, 1 publications between 2012 and 2012, average publication date March 2012. Cytotoxicity, Immunologic, 1 publications between 2012 and 2012, average publication date March 2012. Melanoma, Experimental, 1 publications between 2012 and 2012, average publication date March 2012. Myeloid Differentiation Factor 88, 1 publications between 2012 and 2012, average publication date March 2012. T-Lymphocytes, Cytotoxic, 1 publications between 2012 and 2012, average publication date March 2012. CD8-Positive T-Lymphocytes, 2 publications between 2012 and 2014, average publication date April 2013. Dendritic Cells, 2 publications between 2012 and 2014, average publication date April 2013. Antigen Presentation, 1 publications between 2014 and 2014, average publication date June 2014. Tobacco Mosaic Virus, 1 publications between 2014 and 2014, average publication date June 2014. CD8 Antigens, 1 publications between 2020 and 2020, average publication date January 2020. Carcinoma, Squamous Cell, 2 publications between 2020 and 2021, average publication date August 2020. Risk, 2 publications between 2020 and 2021, average publication date October 2020. Papillomaviridae, 2 publications between 2020 and 2022, average publication date January 2021. Oropharyngeal Neoplasms, 3 publications between 2020 and 2022, average publication date March 2021. Otorhinolaryngologic Surgical Procedures, 1 publications between 2021 and 2021, average publication date July 2021. Tumor Microenvironment, 2 publications between 2020 and 2024, average publication date March 2022. Head and Neck Neoplasms, 4 publications between 2021 and 2023, average publication date May 2022. Metformin, 2 publications between 2021 and 2023, average publication date July 2022.

Antigens, Neoplasm
CD40 Antigens
Cytotoxicity, Immunologic
Melanoma, Experimental
Myeloid Differentiation Factor 88
T-Lymphocytes, Cytotoxic
CD8-Positive T-Lymphocytes
Dendritic Cells
Antigen Presentation
Tobacco Mosaic Virus
CD8 Antigens
Carcinoma, Squamous Cell
Risk
Papillomaviridae
Oropharyngeal Neoplasms
Otorhinolaryngologic Surgical Procedures
Tumor Microenvironment
Head and Neck Neoplasms
Metformin

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Antigens, Neoplasm	1	2012	2012	March 2012
CD40 Antigens	1	2012	2012	March 2012
Cytotoxicity, Immunologic	1	2012	2012	March 2012
Melanoma, Experimental	1	2012	2012	March 2012
Myeloid Differentiation Factor 88	1	2012	2012	March 2012
T-Lymphocytes, Cytotoxic	1	2012	2012	March 2012
CD8-Positive T-Lymphocytes	2	2012	2014	April 2013
Dendritic Cells	2	2012	2014	April 2013
Antigen Presentation	1	2014	2014	June 2014
Tobacco Mosaic Virus	1	2014	2014	June 2014
CD8 Antigens	1	2020	2020	January 2020
Carcinoma, Squamous Cell	2	2020	2021	August 2020
Risk	2	2020	2021	October 2020
Papillomaviridae	2	2020	2022	January 2021
Oropharyngeal Neoplasms	3	2020	2022	March 2021
Otorhinolaryngologic Surgical Procedures	1	2021	2021	July 2021
Tumor Microenvironment	2	2020	2024	March 2022
Head and Neck Neoplasms	4	2021	2023	May 2022
Metformin	2	2021	2023	July 2022

KEMNADE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (80)

Explore

Co-Authors (22)

Explore

Similar People (60)

Explore

Same Department

Explore